Pnc Financial Services Group, Inc. Krystal Biotech, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 2,141 shares of KRYS stock, worth $284,838. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,141
Previous 1,680
27.44%
Holding current value
$284,838
Previous $263,000
46.77%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding KRYS
# of Institutions
328Shares Held
24.3MCall Options Held
299KPut Options Held
97.6K-
Black Rock Inc. New York, NY3.95MShares$525 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.83MShares$376 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.73MShares$363 Million7.97% of portfolio
-
State Street Corp Boston, MA1.23MShares$163 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA954KShares$127 Million0.03% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.41B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...